ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
In BRAF mutant melanoma, inhibition of ERK1/2 induces FOXD3 and mediates RAF inhibitor resistance. Here, the authors show that ERK1/2 mediated phosphorylation regulates sumoylation of SOX10 which activates FOXD3, and depletion of SOX10 sensitises BRAF mutant melanoma cells to RAF inhibitors.
Saved in:
Main Authors: | Shujun Han, Yibo Ren, Wangxiao He, Huadong Liu, Zhe Zhi, Xinliang Zhu, Tielin Yang, Yu Rong, Bohan Ma, Timothy J. Purwin, Zhenlin Ouyang, Caixia Li, Xun Wang, Xueqiang Wang, Huizi Yang, Yan Zheng, Andrew E. Aplin, Jiankang Liu, Yongping Shao |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/829318fdf04b499a9e045b0d41cff81a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
by: Shujun Han, et al.
Published: (2018) -
K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling
by: Qing Yin, et al.
Published: (2019) -
Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors
by: Matthew J. Sale, et al.
Published: (2019) -
Clinical responses to ERK inhibition in BRAF V600E-mutant colorectal cancer predicted using a computational model
by: Daniel C. Kirouac, et al.
Published: (2017) -
Epithelial expression of Gata4 and Sox2 regulates specification of the squamous–columnar junction via MAPK/ERK signaling in mice
by: Nao Sankoda, et al.
Published: (2021)